Axonics Statistics
Total Valuation
Axonics has a market cap or net worth of $3.40 billion. The enterprise value is $3.07 billion.
| Market Cap | 3.40B |
| Enterprise Value | 3.07B |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
| Earnings Date | May 7, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Axonics has 51.00 million shares outstanding. The number of shares has increased by 5.13% in one year.
| Shares Outstanding | 51.00M |
| Shares Change (YoY) | +5.13% |
| Shares Change (QoQ) | -1.36% |
| Owned by Insiders (%) | 1.07% |
| Owned by Institutions (%) | 100.71% |
| Float | 50.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 163.25 |
| PS Ratio | 9.28 |
| Forward PS | 7.45 |
| PB Ratio | 5.34 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.38 |
| EV / EBITDA | 984.73 |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.73, with a Debt / Equity ratio of 0.04.
| Current Ratio | 10.73 |
| Quick Ratio | 9.06 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | 8.85 |
| Debt / FCF | n/a |
| Interest Coverage | 15.01 |
Financial Efficiency
Return on equity (ROE) is -1.00% and return on invested capital (ROIC) is -3.92%.
| Return on Equity (ROE) | -1.00% |
| Return on Assets (ROA) | -0.90% |
| Return on Capital (ROIC) | -3.92% |
| Revenue Per Employee | $459,698 |
| Profits Per Employee | -$7,639 |
| Employee Count | 797 |
| Asset Turnover | 0.54 |
| Inventory Turnover | 1.35 |
Taxes
| Income Tax | -2.66M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.10% in the last 52 weeks. The beta is 0.59, so Axonics's price volatility has been lower than the market average.
| Beta (1Y) | 0.59 |
| 52-Week Price Change | +16.10% |
| 50-Day Moving Average | 67.88 |
| 200-Day Moving Average | 60.94 |
| Relative Strength Index (RSI) | 36.40 |
| Average Volume (30 Days) | 886,319 |
Short Selling Information
The latest short interest is 4.04 million, so 7.92% of the outstanding shares have been sold short.
| Short Interest | 4.04M |
| Short Previous Month | 3.44M |
| Short % of Shares Out | 7.92% |
| Short % of Float | 8.01% |
| Short Ratio (days to cover) | 3.64 |
Income Statement
In the last 12 months, Axonics had revenue of $366.38 million and -$6.09 million in losses. Loss per share was -$0.12.
| Revenue | 366.38M |
| Gross Profit | 274.55M |
| Operating Income | -26.06M |
| Pretax Income | -8.74M |
| Net Income | -6.09M |
| EBITDA | 3.12M |
| EBIT | -9.37M |
| Loss Per Share | -$0.12 |
Balance Sheet
The company has $357.67 million in cash and $27.62 million in debt, giving a net cash position of $330.06 million or $6.47 per share.
| Cash & Cash Equivalents | 357.67M |
| Total Debt | 27.62M |
| Net Cash | 330.06M |
| Net Cash Per Share | $6.47 |
| Equity / Book Value | 637.56M |
| Book Value Per Share | 12.50 |
| Working Capital | 445.61M |
Cash Flow
In the last 12 months, operating cash flow was -$2.02 million and capital expenditures -$3.55 million, giving a free cash flow of -$5.57 million.
| Operating Cash Flow | -2.02M |
| Capital Expenditures | -3.55M |
| Free Cash Flow | -5.57M |
| FCF Per Share | -$0.11 |
Margins
Gross margin is 74.94%, with operating and profit margins of -7.11% and -1.66%.
| Gross Margin | 74.94% |
| Operating Margin | -7.11% |
| Pretax Margin | -2.39% |
| Profit Margin | -1.66% |
| EBITDA Margin | 0.85% |
| EBIT Margin | -2.56% |
| FCF Margin | -1.52% |
Dividends & Yields
Axonics does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -5.13% |
| Shareholder Yield | -5.13% |
| Earnings Yield | -0.18% |
| FCF Yield | -0.16% |
Analyst Forecast
The average price target for Axonics is $71.25, which is 6.84% higher than the current price. The consensus rating is "Hold".
| Price Target | $71.25 |
| Price Target Difference | 6.84% |
| Analyst Consensus | Hold |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 19.35% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Axonics has an Altman Z-Score of 25.25 and a Piotroski F-Score of 4.
| Altman Z-Score | 25.25 |
| Piotroski F-Score | 4 |